Serotonin HTR1 group and FOS pathway

Pathway network for the Serotonin HTR1 group and FOS pathway SuperPath

Sources:

WikiPathways

Pathways in the Serotonin HTR1 group and FOS pathway SuperPath

#	Name	Source	Genes
1	Serotonin HTR1 group and FOS pathway	WikiPathways	BRAF CREB1 ELK1 ELK4 FOS GNAQ HTR2A ITPR1 JAK2 MAP2K1 MAP2K2 MAP2K3 MAP2K6 MAP3K1 MAPK14 MAPK3 MAPKAPK2 MAPKAPK3 PDPK1 PIK3CA RAP1A RASGRF1 RASGRP1 RHOA RPS6KA5 SRF STAT3 (see all 27) (see less)
2	Serotonin receptor 2 and ELK-SRF/GATA4 signaling	WikiPathways	ELK1 ELK4 GATA4 GNAQ HRAS HTR2A HTR2B HTR2C ITPR1 KRAS MAP2K1 MAP2K2 MAPK3 MAPKAPK2 NRAS RAF1 RASGRF1 RASGRP1 SRF (see all 19) (see less)
3	Serotonin receptor 4/6/7 and NR3C signaling	WikiPathways	ATF1 BRAF CREB1 EGR1 ELK1 ELK4 GNAS HTR4 HTR6 HTR7 MAP2K1 MAP2K2 MAPK3 MAPKAPK2 NR3C1 RAP1A RPS6KA5 SRF (see all 18) (see less)
4	Serotonin receptor 2 and STAT3 signaling	WikiPathways	GNAQ HTR2A JAK2 STAT3
5	TROP2 regulatory signaling	WikiPathways	JAK2

Gene overlap in member pathways for Serotonin HTR1 group and FOS pathway SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	SRF	Serum Response Factor	Protein Coding	3
2	MAP2K2	Mitogen-Activated Protein Kinase Kinase 2	Protein Coding	3
3	MAP2K1	Mitogen-Activated Protein Kinase Kinase 1	Protein Coding	3
4	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	3
5	JAK2	Janus Kinase 2	Protein Coding	3
6	HTR2A	5-Hydroxytryptamine Receptor 2A	Protein Coding	3
7	GNAQ	G Protein Subunit Alpha Q	Protein Coding	3
8	MAPKAPK2	MAPK Activated Protein Kinase 2	Protein Coding	3
9	ELK4	ETS Transcription Factor ELK4	Protein Coding	3
10	ELK1	ETS Transcription Factor ELK1	Protein Coding	3
11	RAP1A	RAP1A, Member Of RAS Oncogene Family	Protein Coding	2
12	RPS6KA5	Ribosomal Protein S6 Kinase A5	Protein Coding	2
13	STAT3	Signal Transducer And Activator Of Transcription 3	Protein Coding	2
14	BRAF	B-Raf Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	2
15	RASGRF1	Ras Protein Specific Guanine Nucleotide Releasing Factor 1	Protein Coding	2
16	ITPR1	Inositol 1,4,5-Trisphosphate Receptor Type 1	Protein Coding	2
17	CREB1	CAMP Responsive Element Binding Protein 1	Protein Coding	2
18	RASGRP1	RAS Guanyl Releasing Protein 1	Protein Coding	2
19	MAPKAPK3	MAPK Activated Protein Kinase 3	Protein Coding	1
20	MAP2K6	Mitogen-Activated Protein Kinase Kinase 6	Protein Coding	1
21	MAP2K3	Mitogen-Activated Protein Kinase Kinase 3	Protein Coding	1
22	PIK3CA	Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha	Protein Coding	1
23	PDPK1	3-Phosphoinositide Dependent Protein Kinase 1	Protein Coding	1
24	MAP3K1	Mitogen-Activated Protein Kinase Kinase Kinase 1	Protein Coding	1
25	RHOA	Ras Homolog Family Member A	Protein Coding	1
26	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
27	MAPK14	Mitogen-Activated Protein Kinase 14	Protein Coding	1
28	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
29	NRAS	NRAS Proto-Oncogene, GTPase	Protein Coding	1
30	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	1
31	HTR2C	5-Hydroxytryptamine Receptor 2C	Protein Coding	1
32	HTR2B	5-Hydroxytryptamine Receptor 2B	Protein Coding	1
33	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	1
34	GATA4	GATA Binding Protein 4	Protein Coding	1
35	ATF1	Activating Transcription Factor 1	Protein Coding	1
36	HTR7	5-Hydroxytryptamine Receptor 7	Protein Coding	1
37	HTR6	5-Hydroxytryptamine Receptor 6	Protein Coding	1
38	HTR4	5-Hydroxytryptamine Receptor 4	Protein Coding	1
39	NR3C1	Nuclear Receptor Subfamily 3 Group C Member 1	Protein Coding	1
40	GNAS	GNAS Complex Locus	Protein Coding	1
41	EGR1	Early Growth Response 1	Protein Coding	1

Disorders associated with Serotonin HTR1 group and FOS pathway SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Rasopathy	Enrichment	HRAS, KRAS, MAP2K1, MAP2K2, NRAS, RAF1	11.19
2	Noonan syndrome 1	Enrichment	HRAS, KRAS, MAP2K1, MAP2K2, NRAS, RAF1	10.60
3	Noonan syndrome and noonan-related syndrome	Enrichment	HRAS, KRAS, MAP2K1, MAP2K2, NRAS, RAF1	10.56
4	Lung non-small cell carcinoma	Enrichment	HRAS, KRAS, MAP2K1, NRAS	9.04
5	Cardiofaciocutaneous syndrome 1	Enrichment	BRAF, MAP2K1, MAP2K2	8.11
6	Cardiofaciocutaneous syndrome	Enrichment	BRAF, MAP2K1, MAP2K2	8.11
7	Schimmelpenning-feuerstein-mims syndrome	Enrichment	HRAS, KRAS, NRAS	8.03
8	Nevus, epidermal	Enrichment	HRAS, KRAS, NRAS	7.09
9	Noonan syndrome 3	Enrichment	HRAS, KRAS, RAF1	7.09
10	Melanocytic nevus syndrome, congenital	Enrichment	HRAS, NRAS, RAF1	6.89
11	Primary hyperaldosteronism	Enrichment	BRAF, GNAS, NR3C1	6.79
12	Breast implant-associated anaplastic large cell lymphoma	Enrichment	JAK2, STAT3	6.71
13	Ras-associated autoimmune leukoproliferative disorder	Enrichment	KRAS, NRAS	5.73
14	Langerhans cell histiocytosis	Enrichment	BRAF, MAP2K1	5.30
15	Melanoma of soft tissue	Enrichment	ATF1, CREB1	5.30
16	Large congenital melanocytic nevus	Enrichment	HRAS, NRAS	5.25
17	Differentiated thyroid carcinoma	Enrichment	HRAS, KRAS, NRAS	5.08
18	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	KRAS, NRAS	4.95
19	Capillary malformations, congenital	Enrichment	GNAQ, PIK3CA	4.42
20	Thyroid cancer, nonmedullary, 2	Enrichment	HRAS, NRAS	4.41
21	Capillary malformation-arteriovenous malformation 1	Enrichment	KRAS, MAP2K1	4.41
22	Leukemia, chronic myeloid	Enrichment	KRAS, NRAS	4.41
23	Pilomyxoid astrocytoma	Enrichment	KRAS, RAF1	4.41
24	Follicular thyroid carcinoma	Enrichment	HRAS, NRAS	4.41
25	Klippel-trenaunay-weber syndrome	Enrichment	GNAQ, PIK3CA	4.24
26	Hemihyperplasia, isolated	Enrichment	PIK3CA, RHOA	4.24
27	Arteriovenous malformation	Enrichment	HRAS, MAP2K1	4.18
28	Gallbladder cancer	Enrichment	BRAF, PIK3CA	4.10
29	Myopathy, x-linked, with excessive autophagy	Enrichment	HRAS, MAP2K1	4.08
30	Juvenile myelomonocytic leukemia	Enrichment	KRAS, NRAS	3.91
31	Thrombocythemia 3	Enrichment	JAK2	3.83
32	Polycythemia	Enrichment	JAK2	3.83
33	Hypereosinophilic syndrome	Enrichment	JAK2	3.83
34	Polycythemia vera	Enrichment	JAK2	3.66
35	Lip and oral cavity carcinoma	Enrichment	BRAF, PIK3CA	3.60
36	Sturge-weber syndrome	Enrichment	GNAQ	3.53
37	T-cell large granular lymphocyte leukemia	Enrichment	STAT3	3.53
38	Autoimmune disease, multisystem, infantile-onset, 1	Enrichment	STAT3	3.53
39	Stat3-related early-onset multisystem autoimmune disease	Enrichment	STAT3	3.53
40	Chronic lymphoproliferative disorder of natural killer cells	Enrichment	STAT3	3.53
41	Erythrocytosis, familial, 1	Enrichment	JAK2	3.53
42	Budd-chiari syndrome	Enrichment	JAK2	3.53
43	Myeloproliferative neoplasm	Enrichment	JAK2	3.43
44	Myelofibrosis	Enrichment	JAK2	3.29
45	Essential thrombocythemia	Enrichment	JAK2	3.29
46	Obsessive-compulsive disorder	Enrichment	HTR2A	3.23
47	Phakomatosis cesioflammea	Enrichment	GNAQ	3.23
48	Diffuse large b-cell lymphoma	Enrichment	BRAF, STAT3	3.19
49	Leukemia, acute lymphoblastic 3	Enrichment	JAK2	3.18
50	Bladder cancer	Enrichment	HRAS, KRAS	3.13
51	Non-immune hydrops fetalis	Enrichment	HRAS, KRAS	3.07
52	Hyper-ige syndrome 1, autosomal dominant, with recurrent infections	Enrichment	STAT3	3.05
53	Hyper ige syndrome	Enrichment	STAT3	3.05
54	Anastomosing haemangioma	Enrichment	GNAQ	3.05
55	Pseudohypoparathyroidism, type ic	Enrichment	GNAS	2.88
56	Melorheostosis, isolated	Enrichment	MAP2K1	2.88
57	Osseous heteroplasia, progressive	Enrichment	GNAS	2.88
58	Noonan syndrome 7	Enrichment	BRAF	2.88
59	Leopard syndrome 3	Enrichment	BRAF	2.88
60	Cardiofaciocutaneous syndrome 3	Enrichment	MAP2K1	2.88
61	Glucocorticoid resistance, generalized	Enrichment	NR3C1	2.88
62	Acth-independent macronodular adrenal hyperplasia 1	Enrichment	GNAS	2.88
63	Pituitary adenoma 3, multiple types	Enrichment	GNAS	2.88
64	Lymphangioma	Enrichment	BRAF	2.88
65	Phace association	Enrichment	BRAF	2.88
66	Melorheostosis	Enrichment	MAP2K1	2.88
67	Cardiofaciocutaneous syndrome 4	Enrichment	MAP2K2	2.88
68	Disorders of gnas inactivation	Enrichment	GNAS	2.88
69	Syringocystadenoma papilliferum	Enrichment	BRAF	2.88
70	Ganglioglioma	Enrichment	BRAF	2.88
71	Nongerminomatous germ cell tumor	Enrichment	BRAF	2.88
72	Monostotic fibrous dysplasia	Enrichment	GNAS	2.88
73	Phace syndrome	Enrichment	BRAF	2.88
74	Classic hairy cell leukemia	Enrichment	BRAF	2.88
75	Mazabraud syndrome	Enrichment	GNAS	2.88
76	Oculoectodermal syndrome	Enrichment	KRAS	2.85
77	Noonan syndrome 5	Enrichment	RAF1	2.85
78	Cardiomyopathy, dilated, 1nn	Enrichment	RAF1	2.85
79	Melanosis, neurocutaneous	Enrichment	NRAS	2.85
80	Noonan syndrome 6	Enrichment	NRAS	2.85
81	Atrioventricular septal defect 4	Enrichment	GATA4	2.85
82	Immunodeficiency 64 with lymphoproliferation	Enrichment	RASGRP1	2.85
83	Cardiofaciocutaneous syndrome 2	Enrichment	KRAS	2.85
84	Atrial septal defect 2	Enrichment	GATA4	2.85
85	Leopard syndrome 2	Enrichment	RAF1	2.85
86	Testicular anomalies with or without congenital heart disease	Enrichment	GATA4	2.85
87	8p23.1 microdeletion syndrome	Enrichment	GATA4	2.85
88	Trigonitis	Enrichment	RAF1	2.85
89	Congenital pulmonary airway malformation	Enrichment	KRAS	2.85
90	Immunodeficiency 64	Enrichment	RASGRP1	2.85
91	Ebv-induced lymphoproliferative disease due to rasgrp1 deficiency	Enrichment	RASGRP1	2.85
92	Partial atrioventricular septal defect with ventricular hypoplasia	Enrichment	GATA4	2.85
93	Phakomatosis pigmentokeratotica	Enrichment	HRAS	2.85
94	Neurocutaneous melanocytosis	Enrichment	NRAS	2.85
95	Leukemia, acute myeloid	Enrichment	KRAS, NRAS	2.85
96	Major depressive disorder	Enrichment	HTR2A	2.83
97	Melanoma, uveal	Enrichment	GNAQ	2.75
98	Lung cancer	Enrichment	BRAF, PIK3CA	2.74
99	Macrodactyly	Enrichment	PIK3CA	2.70
100	Megalencephaly, autosomal dominant	Enrichment	PIK3CA	2.70
101	Cowden syndrome 5	Enrichment	PIK3CA	2.70
102	46,xy sex reversal 6	Enrichment	MAP3K1	2.70
103	Cerebral cavernous malformations 4	Enrichment	PIK3CA	2.70
104	Hemifacial myohyperplasia	Enrichment	PIK3CA	2.70
105	Capillary malformation of the lower lip, lymphatic malformation of face and neck, asymmetry of face and limbs, and partial/generalized overgrowth	Enrichment	PIK3CA	2.70
106	Macular dystrophy, patterned, 3	Enrichment	MAPKAPK3	2.70
107	Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies	Enrichment	RHOA	2.70
108	Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies	Enrichment	RHOA	2.70
109	Segmental progressive overgrowth syndrome with fibroadipose hyperplasia	Enrichment	PIK3CA	2.70
110	Hypospadias	Enrichment	PIK3CA	2.70
111	Rare venous malformation	Enrichment	PIK3CA	2.70
112	Diaphragmatic eventration	Enrichment	PIK3CA	2.70
113	Pik3ca-related overgrowth spectrum	Enrichment	PIK3CA	2.70
114	Rare combined vascular malformation	Enrichment	PIK3CA	2.70
115	Cavernous lymphangioma	Enrichment	PIK3CA	2.70
116	Pik3ca-related overgrowth syndrome	Enrichment	PIK3CA	2.70
117	Hemihyperplasia-multiple lipomatosis syndrome	Enrichment	PIK3CA	2.70
118	Eccrine angiomatous hamartoma	Enrichment	PIK3CA	2.70
119	Macrodactyly of toe	Enrichment	PIK3CA	2.70
120	Permanent neonatal diabetes mellitus	Enrichment	STAT3	2.63
121	Pseudohypoparathyroidism, type ia	Enrichment	GNAS	2.58
122	Galactosemia ii	Enrichment	NR3C1	2.58
123	Pulmonic stenosis	Enrichment	BRAF	2.58
124	Histiocytoma, angiomatoid fibrous	Enrichment	CREB1	2.58
125	Pigmented nodular adrenocortical disease, primary, 1	Enrichment	GNAS	2.58
126	Pseudopseudohypoparathyroidism	Enrichment	GNAS	2.58
127	Pseudohypoparathyroidism	Enrichment	GNAS	2.58
128	Acth-independent macronodular adrenal hyperplasia	Enrichment	GNAS	2.58
129	Tafro syndrome	Enrichment	MAP2K2	2.58
130	Spinocerebellar ataxia 29	Enrichment	ITPR1	2.55
131	Costello syndrome	Enrichment	HRAS	2.55
132	Encephalocraniocutaneous lipomatosis	Enrichment	KRAS	2.55
133	46,xy sex reversal 3	Enrichment	GATA4	2.55
134	Wooly hair nevus	Enrichment	HRAS	2.55
135	Acute promyelocytic leukemia	Enrichment	STAT3	2.42
136	Mccune-albright syndrome	Enrichment	GNAS	2.40
137	Ataxia-telangiectasia	Enrichment	BRAF	2.40
138	Tethered spinal cord syndrome	Enrichment	BRAF	2.40
139	Cushing syndrome due to bilateral macronodular adrenocortical disease	Enrichment	GNAS	2.40
140	Keratosis, seborrheic	Enrichment	PIK3CA	2.40
141	Noonan syndrome 8	Enrichment	PIK3CA	2.40
142	Rosette-forming glioneuronal tumor	Enrichment	PIK3CA	2.40
143	Gillespie syndrome	Enrichment	ITPR1	2.38
144	Spermatocytoma	Enrichment	HRAS	2.38
145	Primary ovarian insufficiency	Enrichment	JAK2	2.36
146	Thyroid cancer, nonmedullary, 1	Enrichment	BRAF	2.28
147	Pseudohypoparathyroidism, type ib	Enrichment	GNAS	2.28
148	Neurofibromatosis-noonan syndrome	Enrichment	MAP2K2	2.28
149	Craniopharyngioma	Enrichment	BRAF	2.28
150	Noonan syndrome with multiple lentigines	Enrichment	BRAF	2.28
151	Newborn respiratory distress syndrome	Enrichment	BRAF	2.28
152	Diffuse gastric and lobular breast cancer syndrome	Enrichment	KRAS	2.25
153	Spinocerebellar ataxia 15	Enrichment	ITPR1	2.25
154	Lung sarcomatoid carcinoma	Enrichment	KRAS	2.25
155	Pilocytic astrocytoma	Enrichment	KRAS	2.25
156	Epidermolytic nevus	Enrichment	HRAS	2.25
157	Transposition of the great arteries	Enrichment	GATA4	2.25
158	Pompe disease, infantile-onset	Enrichment	PIK3CA	2.22
159	Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi	Enrichment	PIK3CA	2.22
160	Bacteremia 2	Enrichment	MAPKAPK3	2.22
161	Keratoacanthoma	Enrichment	PIK3CA	2.22
162	Ventricular septal defect 1	Enrichment	GATA4	2.16
163	Congenital heart defects, multiple types, 4	Enrichment	GATA4	2.16
164	Wilms tumor 5	Enrichment	BRAF	2.10
165	Megalencephaly-capillary malformation-polymicrogyria syndrome	Enrichment	PIK3CA	2.10
166	Congenital generalized lipodystrophy	Enrichment	FOS	2.10
167	Cerebrovascular disease	Enrichment	PIK3CA	2.10
168	Tuberculosis	Enrichment	MAPKAPK3	2.10
169	Familial cerebral cavernous malformations	Enrichment	PIK3CA	2.10
170	Spinocerebellar ataxia, autosomal recessive 16	Enrichment	ITPR1	2.08
171	Breast adenocarcinoma	Enrichment	KRAS	2.08
172	Lung squamous cell carcinoma	Enrichment	KRAS	2.08
173	Brachydactyly	Enrichment	GNAS	2.03
174	Histiocytoid hemangioma	Enrichment	FOS	2.00
175	Hemimegalencephaly	Enrichment	PIK3CA	2.00
176	Spastic paraplegia 4, autosomal dominant	Enrichment	GNAS	1.98
177	Lymphoma, non-hodgkin, familial	Enrichment	BRAF	1.98
178	Cardiomyopathy, familial hypertrophic, 4	Enrichment	BRAF	1.93
179	Ventricular septal defect	Enrichment	BRAF	1.93
180	Cowden syndrome 1	Enrichment	PIK3CA	1.92
181	Colorectal cancer	Enrichment	BRAF, PIK3CA	1.89
182	Melanoma	Enrichment	BRAF	1.88
183	Ovarian cancer	Enrichment	MAP3K1, PIK3CA	1.77
184	Schizophrenia	Enrichment	HTR2A	1.76
185	Adult hepatocellular carcinoma	Enrichment	PIK3CA	1.75
186	Cowden syndrome	Enrichment	PIK3CA	1.75
187	Protein-deficiency anemia	Enrichment	NRAS	1.74
188	Lung cancer susceptibility 3	Enrichment	BRAF	1.73
189	Multiple sclerosis	Enrichment	ITPR1	1.71
190	Aortic aneurysm, familial thoracic 1	Enrichment	GATA4	1.71
191	Heart disease	Enrichment	GATA4	1.71
192	46,xy partial gonadal dysgenesis	Enrichment	GATA4	1.71
193	Wilms tumor 1	Enrichment	BRAF	1.70
194	Anterior segment dysgenesis	Enrichment	ITPR1	1.68
195	Lynch syndrome	Enrichment	KRAS	1.68
196	46,xy complete gonadal dysgenesis	Enrichment	MAP3K1	1.66
197	Rhabdomyosarcoma	Enrichment	HRAS	1.65
198	Melanoma, cutaneous malignant 1	Enrichment	BRAF	1.65
199	Dandy-walker syndrome	Enrichment	BRAF	1.65
200	Meningioma	Enrichment	PIK3CA	1.63
201	Heart, malformation of	Enrichment	GATA4	1.60
202	Patent foramen ovale	Enrichment	GATA4	1.60
203	Arteriovenous malformations of the brain	Enrichment	BRAF	1.60
204	Cardiomyopathy, familial hypertrophic, 1	Enrichment	RAF1	1.48
205	Familial atrial fibrillation	Enrichment	GATA4	1.48
206	Pancreatic cancer	Enrichment	KRAS	1.46
207	Tetralogy of fallot	Enrichment	GATA4	1.45
208	Hydrops fetalis, nonimmune	Enrichment	HRAS	1.45
209	Endometrial cancer	Enrichment	PIK3CA	1.39
210	Hepatocellular carcinoma	Enrichment	PIK3CA	1.37
211	Malaria	Enrichment	MAPKAPK3	1.35
212	Familial hypertrophic cardiomyopathy	Enrichment	RAF1	1.34
213	Left ventricular noncompaction	Enrichment	RAF1	1.32
214	Prostate cancer	Enrichment	PIK3CA	1.25
215	Gastric cancer	Enrichment	KRAS	1.23
216	Hereditary breast carcinoma	Enrichment	KRAS	1.22
217	Body mass index quantitative trait locus 11	Enrichment	GNAS	1.19
218	Spastic ataxia	Enrichment	ITPR1	1.14
219	Familial isolated dilated cardiomyopathy	Enrichment	RAF1	1.14
220	Myeloma, multiple	Enrichment	BRAF	1.14
221	Hereditary breast ovarian cancer syndrome	Enrichment	KRAS	1.13
222	Male infertility with azoospermia or oligozoospermia due to single gene mutation	Enrichment	GATA4	1.12
223	Hypertelorism	Enrichment	PIK3CA	1.01
224	Breast cancer	Enrichment	KRAS	1.00
225	Dilated cardiomyopathy	Enrichment	BRAF	1.00
226	Autism spectrum disorder	Enrichment	MAP2K1	0.87

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Serotonin HTR1 group and FOS pathway

Pathway Network for Serotonin HTR1 group and FOS pathway

Pathway network for the Serotonin HTR1 group and FOS pathway SuperPath

Member Pathways for Serotonin HTR1 group and FOS pathway

Pathways in the Serotonin HTR1 group and FOS pathway SuperPath

Gene overlap in member pathways for Serotonin HTR1 group and FOS pathway SuperPath

Associated Genes for Serotonin HTR1 group and FOS pathway

Associated Disorders for Serotonin HTR1 group and FOS pathway

Disorders associated with Serotonin HTR1 group and FOS pathway SuperPath

STRING Interaction Network for Serotonin HTR1 group and FOS pathway

Sources for Serotonin HTR1 group and FOS pathway